Compared to age- and sex-matched healthy donors, CLL patients show significantly higher levels of A2A and the expression of this receptor is further increased in response to signals inducing CLL proliferation, such as TLR9 agonists and IL-2. This evidence concerns the gene TLR9 and B-cell chronic lymphocytic leukemia.